Item 7.01 Regulation FD Disclosure.
On
·HCW Wainwright Bioconnect Conference .Mr. Milano , together withDr. Elizabeth Tarka, Chief Medical Officer of the Company and Mr.John Kirby , Chief Financial Officer of the Company, will be participating in a virtual fireside chat at theHCW Wainwright Bioconnect Conference . For those registered for the conference, a video will be available on-demand during the week ofJanuary 11-14, 2021 . The Company will also post the video on its website at6 AM Eastern onMonday, January 11, 2021 , which can be accessed via Investor Relations section of the Company's website at https://ir.iderapharma.com/. · 39th AnnualJPMorgan Healthcare Conference . OnJanuary 13, 2021 ,Mr. Milano will be presenting at the 39th AnnualJPMorgan Healthcare Conference at3:40 PM Eastern Time . A live audio webcast of the presentation on the Investor Relations section of the Company's website at https://ir.iderapharma.com/.
The press release furnished as Exhibit 99.1 to this Current Report on Form 8-K is incorporated herein by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release datedJanuary 11, 2021 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
© Edgar Online, source